Executive leadership at Cardio Diagnostics Holdings.
Board of directors at Cardio Diagnostics Holdings.
Research analysts covering Cardio Diagnostics Holdings.
Recent press releases and 8-K filings for CDIO.
Cardio Diagnostics Regains Nasdaq Listing Compliance
CDIO
Delisting/Listing Issues
- Cardio Diagnostics Holdings, Inc. filed a Form 8-K on May 28, 2025, reporting key updates regarding its Nasdaq listing status.
- The company received notice confirming that its common stock closing price was $1.00 or greater for 10 consecutive business days (May 13–May 27, 2025), thereby regaining compliance with Nasdaq's minimum bid price requirement.
May 28, 2025, 12:00 AM
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more